AGP Executive Report
Last update: 11 hours agoPTSD Treatment Breakthrough: A new Nature Medicine study reports FDA-approved synthetic THC (dronabinol) can reduce the frequency and intensity of PTSD nightmares, pointing to a clearer medical role for cannabinoid drugs in sleep and symptom relief. Hemp Ban Fight: The White House-backed push to delay a federal ban on intoxicating hemp products is colliding with a fast-moving government funding bill, with GOP senators vowing to kill the hemp delay measure over kids’ access concerns. Regulatory Access in New York: New York law expands where licensed cannabis microbusinesses can sell, allowing participation in “Cannabis Showcase Events” at approved farmers markets and pop-ups—aimed at boosting smaller operators. Courtroom Cannabis Reality Checks: Ontario’s review board cut a hospital reporting schedule for a man found not criminally responsible twice, while noting cannabis use as a “potent risk factor” tied to his past offenses. Public Safety & Enforcement: Michigan confirmed a fast-spreading invasive “mile-a-minute” weed near a prior detection site, while drug enforcement headlines included a major cannabis trafficking conviction in Malaysia and ongoing anti-drug operations in Pahang.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.